Whalegun
Home

Peter Heerma, Chief Commercial Officer: Travere Therapeutics TVTX Sell · Filed 23/01/26

Trade details

Type
Insider sale
Amount
$33,945
Shares · price
1,550 sh · $21.90 a share
Held after
63,598 sh
Stock
Travere Therapeutics TVTX
Person
Peter HeermaChief Commercial Officer
Trade date
23/01/24
Filed
23/01/26
Days to filing
2 days

Sold 2.4% of holdings

Share of holding sold
2.4%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/25~23/02/23

Peter Heerma's recent trades

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $525.7K

    Filed 09/17

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $10.8M

    Filed 09/16

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $6.7M

    Filed 09/15

  • Peter Heerma

    SellTravere Therapeutics

    $101.4K

    Filed 05/06

  • Peter Heerma

    Planned saleTravere Therapeutics

    $101.4K

    Filed 05/05